Chengguan District, Lanzhou, Gansu, China sales01@liwei-chem.com 1557459043@qq.com
Follow us:



Adipic Acid BP EP USP Pharma Grade: Description and Properties

What is Adipic Acid BP EP USP Pharma Grade?

Adipic acid goes by the chemical formula C6H10O4, a dicarboxylic acid that takes shape as a white, crystalline powder. In pharmaceutical standards, BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) set stringent purity thresholds and composition markers, so manufacturers and drug compounding specialists know exactly what they are dealing with. Pharmaceutical grade adipic acid differs from industrial grades, as it maintains a high purity and keeps impurities and heavy metals to trace levels, which is crucial for processes that end with the raw acid inside a person’s body. Manufacturing batches undergo quality and consistency testing so that each shipment keeps the same level of purity, particle size, and moisture content. This gives drug innovators and manufacturers peace of mind, as poorly characterized inputs can lead to formulation changes and stability problems down the line.

Physical Characteristics and Structure

Adipic acid forms solid, free-flowing white crystals or powder at room temperature. Sometimes, flakes or small pearls take shape depending on the crystallization and drying step. Its density holds steady around 1.36 grams per cubic centimeter, letting process engineers calculate loads precisely when dissolving it in solvents or blending into mixtures. This acid melts near 152 degrees Celsius and boils at temperatures most labs will never see, well above 330 degrees Celsius, so thermal processes in pharma plants rarely risk vaporizing it. Being a straight-chain molecule with six carbons, terminated at both ends by carboxylic acid groups, it stays soluble in hot water but only a little passes into cold water. This modest solubility means it can be used in controlled-release drug bases or as a pH adjuster in solutions and suspensions, since not all of the material will instantly go into solution. The molecular weight registers as 146.14 g/mol, meaning calculations for compounding and solution prep use a round, simple number.

Specifications and Standards

Pharma grade adipic acid follows the standards published by BP, EP, and USP, which document purity, moisture content, residue on ignition, and limits for hazardous substances. Most pharmaceutical applications demand purity above 99.5 percent. Typical moisture content stays below 0.2 percent, and heavy metals such as arsenic, lead, or mercury are held at levels far below standard industrial blends, where limits can be laxer and less suited for drug use. Professionals look for the HS Code 29171200 during import and export, which slots it under carboxylic acids with aldehyde or ketone function. Throughout global trade, this code helps customs officers, logistics providers, and purchasing agents recognize the product instantly for international tracking, tariffs, and audits.

Molecular and Chemical Properties

Molecular structure gives adipic acid its predictable chemical behavior. The two carboxylic groups on each side of the carbon chain react easily in condensation reactions, allowing for use as a raw material in pharmaceutical syntheses. In these reactions, adipic acid reacts with alcohols, amines, or other acids, giving rise to esters, amides, or long-chain polymer families. The solid, stable form minimises the risks of spontaneous decomposition or hazardous outgassing. Yet as a powder or crystal, adipic acid remains slightly harmful if ingested in large quantities or inhaled as dust for prolonged periods, owing to irritation of the respiratory tract or gastrointestinal system. Safety handling procedures matter on the shop floor. Even though it is not classified as acutely toxic, chronic repeated exposure should be avoided by using gloves, goggles, and dust masks. Pharmacopeial references require limits on any trace nitrosamines or foreign contaminants, given mounting evidence that some process by-products can be carcinogenic. Raw materials sourced for pharma-grade adipic acid must provide certificates of analysis, batch traceability, and details describing the absence of prohibited residues.

Forms: Powder, Crystal, Flakes, Pearls, Solution

Laboratory and production teams see adipic acid in several usable forms. Crystals are easy to weigh and dissolve slowly, allowing for precise dosing in batch preparations or pilot plant workups. Flakes and pearls present a dust-free option for automated systems and large-scale pharmaceutical blending. Fine powder accelerates dissolution into water or organic solvents, a helpful property for pharmacists preparing compounding solutions or for excipients in specialized drug delivery applications. Occasionally, solutions of adipic acid are supplied in deionized water, which helps reduce the risk of airborne dust during preparation in cleanrooms and minimizes batch-to-batch variability in concentration. Each form attracts specific storage instructions, since powder and flakes can absorb humidity, caking with time if left open to the atmosphere. Desiccators or moisture-proof containers hold the material stable for long shelf lives, which is necessary when the same inventory lot might be called upon for validation work years after the initial delivery.

Safety, Handling, and Hazards

Adipic acid in its pharmaceutical specification carries less risk than strong acids or volatile chemical intermediates, but diligence in material handling cannot be ignored. The dust can irritate the upper airways or skin, so local exhaust ventilation, personal protective equipment, and careful cleaning of spills keep operations running smoothly. Personnel safety training points out that, despite its low acute toxicity and low flammability, any uncontrolled mixing with incompatible chemicals, such as alkalis, may cause undesirable reactions. Large storage drums, whether made of glass or high-grade polymers, must be labelled with the proper identification and hazard symbols under GHS regulations for chemicals. Storage away from food and other consumables maintains compliance and avoids cross-contamination, especially important where GMP (Good Manufacturing Practice) standards are rigorously applied. Waste management steps in to keep residues and rinses out of water systems, aligning with tightening environmental restrictions in Europe, North America, and Asia.

Uses in Pharmaceuticals and Raw Material Importance

Within the pharmaceutical industry, adipic acid stands out as more than just an excipient or a supporting player in tablet and capsule formation. Its main appeal comes from its dual role as a pH modifier and a raw material source for certain active molecules and delivery agents. By allowing fine-tuning of acidity and acting as a buffer, it helps to stabilize active compounds that would otherwise degrade or lose potency. In controlled-release matrices, the acid can be manipulated to influence the rate and extent of drug solubility, giving formulation chemists another variable to control the onset and duration of therapeutic action. During active pharmaceutical ingredient (API) synthesis, adipic acid serves as a feedstock for intermediate steps, joining other reagents to assemble more complex structures. This essential role cements its status as a backbone molecule for API manufacturing processes worldwide.

Sustainable Sourcing and Industry Ramifications

Current talks in the pharma world often turn to the origin of starting materials and the environmental toll of chemical synthesis. Regular adipic acid processes, based historically on petroleum naphtha and catalytic oxidation, throw out nitrous oxide, a greenhouse gas with a warming potential hundreds of times stronger than carbon dioxide. Some companies push toward biotech routes, using engineered microorganisms to convert sugars or other renewable feedstocks into adipic acid instead. Achieving a low-emission, bio-sourced adipic acid at the same purity and physical property profile as the classic petrochemical version has sent researchers down some very tough and technical paths. To move pharma forward, industry leaders in procurement and sustainability demand third-party documentation, traceability, and verifiable reductions in emissions from their key raw material suppliers. This creates cost pressures, but the market calls for more accountability and environmental stewardship at every step of the pharmaceutical value chain.